---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-031232"
form_type: "8-K"
ticker: "REGN"
cik: "0000872589"
company_name: "REGENERON PHARMACEUTICALS, INC."
filed_at: "2022-03-08T23:59:59+00:00"
generated_at: "2026-06-27T00:57:42.158157+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Regeneron extends $720M lease financing for headquarters by five years to 2027

## Summary
- Five-year extension of $720M lease financing originally from 2017; new maturity March 3, 2027.
- Yield on advances changed to one-month SOFR plus spread adjustment and margin tied to debt rating/leverage.
- Lessee may extend another five years with all Participants' consent; prepayment allowed without premium.
- Guarantors: Regeneron, Regeneron Healthcare Solutions, and Regeneron Genetics Center (joint and several).
- Covenants mirror existing credit agreement: max total leverage ratio, min interest expense coverage, restricted payments test.

## SEC filing metadata
- accession: 0001104659-22-031232
- form_type: 8-K
- ticker: REGN
- cik: 0000872589
- company_name: REGENERON PHARMACEUTICALS, INC.
- filed_at: 2022-03-08T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/872589/000110465922031232/0001104659-22-031232-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/872589/000110465922031232/tm222431d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-031232
- JSON: https://secwatch.observer/filing/0001104659-22-031232.json
- Plain text: https://secwatch.observer/filing/0001104659-22-031232.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.